
BIO International
Date: June 16-19, 2025
Location: Boston Convention & Exhibition Center – Boston, MA
Booth #: 2735
JOIN US!
Come meet our team and learn about our comprehensive, end-to-end CDMO services for biologics, cell and gene therapies, and small molecules. Discover our drug development, clinical supply, and commercial capabilities to take your product from early discovery through market launch.
Complete the form to schedule a meeting with our experts.
NETWORKING EVENT
Alliance for Regenerative Medicine (ARM) Cell & Gene Reception
June 16, 2025 | 6:00pm-8:00pm ET
Join the Alliance for Regenerative Medicine, Catalent and MilliporeSigma for a private reception for cell and gene therapy industry executives during the BIO International Convention. Attendees will enjoy extensive networking opportunities with the sector’s top decision makers including executives from leading companies located in the Boston area!
BOSTON OPEN HOUSE
Catalent Boston Site Tour
June 17 – 18, 2025
We are excited to offer exclusive site tours of our Boston facility, Catalent’s global Center of Excellence for spray dry dispersion and home to the largest pharmaceutical spray-dryer (PSD-7), during the BIO International Convention 2025. This is a unique opportunity to see firsthand how we innovate and drive excellence in drug development and manufacturing of Amorphous Solid Dispersions and large volume spray drying of pharmaceutical ingredients.
Times and spaces are limited, so don’t miss out! To register for the tour, please reach out to Dawn Lovdahl at [email protected].
ABOUT CATALENT
Catalent, Inc. is a leading global contract development and manufacturing organization (CDMO) whose mission is to develop, manufacture, and supply products that help people live better and healthier lives. Catalent is dedicated to delivering unparalleled service to pharma, biotech, and consumer health customers, supporting product development, launch, and full life-cycle supply. With time-tested experience in development sciences, delivery technologies, and multi-modality manufacturing, Catalent supports the acceleration of development programs and the launch of more than a hundred new products every year. Powered by thousands of scientists and technicians and the latest technology platforms at more than 40 global sites, Catalent supplies billions of doses of life-enhancing and life-saving treatments for patients annually. www.catalent.com.